Kala Bio (KALA) Payables (2016 - 2026)
Kala Bio's Payables was $1.14 million in Q2 2026, up 73.6% from $658,000 a year earlier and up 9.4% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, Payables at Kala Bio came in at $986,000, up 57.0% from FY2024.
- Payables shows a five-year compound annual growth rate of -10.6% (FY2020 to FY2025).
- In earlier years, Payables was $628,000 in FY2024 (-31.7%), $919,000 in FY2023 (-67.5%), $2.83 million in FY2022 (-42.2%) and $4.9 million in FY2021 (+184.2%).
- The Q2 2026 figure marks the highest quarterly Payables since Q4 2022.
- Compared with a year earlier, Payables has increased for four straight quarters, with growth averaging 19.6% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q2 2022 (growth of 270.7%); the worst was Q2 2023 (a decline of 92.8%).
- Per Business Quant data, KALA's Payables in the three quarters before Q2 2026 was $1.04 million (Q1 2026), $986,000 (Q4 2025) and $917,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Kala Bio | 2.38 Mn | -42.27 Mn | - | 1.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 986,000.00 |
| Sep 30, 2025 | 917,000.00 |
| Jun 30, 2025 | 658,000.00 |
| Mar 31, 2025 | 931,000.00 |
| Dec 31, 2024 | 628,000.00 |
| Sep 30, 2024 | 711,000.00 |
| Jun 30, 2024 | 665,000.00 |
| Mar 31, 2024 | 732,000.00 |
| Dec 31, 2023 | 919,000.00 |
| Sep 30, 2023 | 787,000.00 |
| Jun 30, 2023 | 760,000.00 |
| Mar 31, 2023 | 997,000.00 |
| Dec 31, 2022 | 2.83 Mn |
| Sep 30, 2022 | 7.35 Mn |
| Jun 30, 2022 | 10.54 Mn |
| Mar 31, 2022 | 6.22 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Sep 30, 2021 | 5.85 Mn |
API Access
Kala Bio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();